Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

AIM Rule 26

20 Aug 2007 07:00

ViaLogy PLC20 August 2007 ViaLogy plc Disclosure of information required by AIM Rule 26 London, 6 August, 2007 - ViaLogy plc (LSE: VIY), a leading innovator ofreal-time network-centric signal processing platforms, today announces that theinformation required by 'Rule 26' of the AIM Rules for Companies is availablewithin the 'Investor Relations' section on the Company's website:www.vialogy.com. For further information please contact: ViaLogyMichael Kelly, CEO - US +1 626-296-6337Terry Bond, Chairman - UK & Europe +44 (0)20 7869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 Seymour Pierce LimitedMark Percy +44 (0)20 107 8000 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defense andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Sep 20078:00 amRNSDirectorate Change
23rd Aug 200711:11 amRNSAdditional Listing
20th Aug 20077:00 amRNSAIM Rule 26
6th Aug 20077:00 amRNSSigns MOU with Taiwan ITRI
20th Jul 200712:21 pmRNSDirectorate Change
13th Jul 200711:58 amRNSDirectorate Change
19th Jun 20077:01 amRNSIssue of Equity
5th Jun 20073:00 pmRNSTechnology Update
30th Apr 200711:07 amRNSCisco purchases SPM Product
30th Apr 20077:49 amRNSBusiness update
18th Apr 20075:33 pmRNSDirector/PDMR Shareholding
18th Apr 20077:01 amRNSDirectorate Change
5th Apr 200710:18 amRNSTechnology Update
28th Mar 20077:02 amRNSLicensing agreement
16th Jan 200712:46 pmRNSHolding(s) in Company
5th Jan 20077:53 amRNSTechnology Update
4th Jan 20077:00 amRNSMilestone Achieved
15th Dec 20065:10 pmRNSTotal Voting Rights
5th Dec 20064:47 pmRNSHolding(s) in Company
1st Dec 200611:28 amRNSInterim Results
30th Oct 20065:18 pmRNSChange of Name
27th Oct 20063:56 pmRNSSch 1 Update- Original Invest
26th Oct 20063:11 pmRNSAGM Statement
6th Oct 20064:28 pmRNSSchedule 1 - Original Invest
27th Sep 200610:30 amRNSAcquisition
27th Sep 200610:30 amRNSFinal Results
11th Sep 20069:02 amRNSDirectorate Change
18th Jul 200612:52 pmRNSHolding(s) in Company
25th Apr 20067:01 amRNSTrading Statement
8th Feb 20063:11 pmRNSHolding(s) in Company
21st Dec 20057:00 amRNSInterim Results
30th Nov 20057:04 amRNSTrading Statement
18th Nov 20057:00 amRNSProduct Launch
29th Sep 200510:07 amRNSResult of AGM, change of name
5th Sep 20057:00 amRNSViaLogy Trading Update
16th Aug 20055:51 pmRNSFinal Results
16th Aug 20057:00 amRNSFinal Results
1st Jun 20053:18 pmRNSDirector Shareholding
25th Jan 20053:17 pmRNSDirector Shareholding
17th Jan 20052:28 pmRNSTrading Statement
5th Jan 20057:00 amRNSDisposal of Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.